2ABF Kraft, Walter - Thomas Jefferson University - Thomas Jefferson University
wxk001

Walter K. Kraft, MD

Contact Dr. Kraft

132 South Tenth Street
1170 Main Building
Philadelphia, PA 19107

(215) 955-9077
(215) 955-5681 fax

Most Recent Peer-reviewed Publications

  1. Posaconazole tablet pharmacokinetics: Lack of effect of concomitant medications altering gastric pH and gastric motility in healthy subjects
  2. Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokinetics
  3. Poor positive predictive value of McConnell's sign on transthoracic echocardiography for the diagnosis of acute pulmonary embolism.
  4. Cardiovascular protection to improve clinical outcomes after subarachnoid hemorrhage: Is there a proven role?
  5. MK-0448, a specific Kv1.5 inhibitor safety, pharmacokinetics, and pharmacodynamic electrophysiology in experimental animal models and humans
  6. Limited Sampling Estimates of Epigallocatechin Gallate Exposures in Cirrhotic and Noncirrhotic Patients With Hepatitis C After Single Oral Doses of Green Tea Extract
  7. Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome
  8. Pharmacokinetics and pharmacodynamics of MK-5046, a bombesin receptor subtype-3 (BRS-3) agonist, in healthy patients
  9. Model for End-Stage Liver Disease score for predicting outcome in critically ill medical patients with liver cirrhosis
  10. Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease
  11. Healthy volunteer registries and ethical research principles
  12. The effect of multiple doses of rifampin and ketoconazole on the single-dose pharmacokinetics of ridaforolimus
  13. Single- and multiple-ascending-dose studies of the NS3 protease inhibitor asunaprevir in subjects with or without chronic hepatitis C
  14. Prevalence of obstructive lung disease in HIV population: A cross sectional study
  15. The effects of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin
  16. Prophylaxis for Deep Vein Thrombosis and Pulmonary Embolism in the Surgical Patient
  17. The incidence of deep vein thrombosis detected by routine surveillance ultrasound in neurosurgery patients receiving dual modality prophylaxis
  18. Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant
  19. The incidence of deep vein thrombosis detected by routine surveillance ultrasound in neurosurgery patients receiving dual modality prophylaxis
  20. Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome
0